UNRV · Unrivaled Brands, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.61M | $8.80M | $8.73M | - | $10.76M | $17.56M | $20.73M | - | $23.43M | $6.26M |
| Cost of Revenue | $4.62M | $4.20M | $4.54M | - | $10.83M | $9.29M | $14.29M | - | $21.15M | $3.92M |
| Gross Profit | $3.99M | $4.60M | $4.18M | - | ($64.0K) | $8.27M | $6.43M | - | $2.29M | $2.34M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $7.53M | $8.07M | $7.10M | - | $13.24M | $19.07M | $18.77M | - | $13.52M | $6.19M |
| Total Operating Expenses | $9.07M | $74.43M | $17.73M | - | $122.74M | - | - | - | - | - |
| D&A | $200.0K | $220.0K | $775.0K | - | $920.0K | $970.0K | $529.0K | - | $1.09M | $930.0K |
| Operating Income | ($5.08M) | ($1.73M) | ($2.92M) | - | ($122.80M) | ($67.07M) | ($12.14M) | - | ($11.23M) | ($3.86M) |
| Interest Expense | $944.0K | $187.0K | $1.02M | - | $384.0K | $443.0K | $1.77M | - | $740.0K | $204.0K |
| Income Tax | $309.0K | ($125.0K) | $658.0K | - | ($3.45M) | $0 | $0 | - | - | - |
| Net Income | ($3.36M) | ($1.44M) | $410.0K | - | ($119.91M) | ($63.72M) | ($8.87M) | - | $5.46M | ($4.11M) |
| EPS - Basic | $0.00 | $0.00 | $0.00 | - | ($0.01) | ($0.02) | ($0.02) | - | - | - |
| EPS - Diluted | $0.00 | $0.00 | $0.00 | - | ($0.01) | ($0.11) | ($0.02) | - | - | - |
Balance Sheet
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.01M | $590.0K | $1.36M | $1.20M | $1.99M | $7.26M | $3.67M | $6.89M | $15.24M | $40.28M |
| Accounts Receivable | $1.28M | $862.0K | $669.0K | $313.0K | $573.0K | $855.0K | $4.03M | $4.68M | $8.43M | $2.20M |
| Inventory | $2.56M | $2.95M | $2.56M | $1.94M | $2.68M | $6.04M | $7.72M | $7.18M | $15.87M | $2.59M |
| Accounts Payable | $12.16M | $10.43M | $12.99M | - | - | - | - | - | - | - |
| Current Assets | $7.05M | $5.72M | $5.53M | $4.58M | $7.21M | $18.20M | $23.63M | $25.26M | $43.55M | $46.11M |
| Total Assets | $36.53M | $38.26M | $39.47M | $40.51M | $53.85M | $180.25M | $249.80M | $271.82M | $259.32M | $106.80M |
| Current Liabilities | $59.04M | $52.82M | $38.61M | $59.14M | $74.54M | $75.44M | $76.38M | $87.71M | $41.85M | $36.68M |
| Long-term Debt | $4.07M | $6.64M | $21.85M | $4.81M | $7.96M | $7.64M | $7.31M | $10.01M | $13.54M | $3.50M |
| Total Liabilities | $73.31M | $71.76M | $73.17M | $77.05M | $95.96M | $103.00M | $105.28M | $125.34M | $63.46M | $47.27M |
| Stockholders' Equity | ($36.78M) | ($33.50M) | ($33.70M) | ($36.54M) | ($42.11M) | $77.25M | $140.39M | $142.63M | $195.86M | $59.53M |
| Retained Earnings | ($444.44M) | ($441.08M) | ($439.64M) | ($440.05M) | ($443.62M) | ($323.71M) | ($258.89M) | ($250.01M) | ($240.27M) | ($234.93M) |
Cash Flow
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($2.27M) | - | - | - | ($3.10M) | - | - | - |
| Investing Cash Flow | - | - | $693.0K | - | - | - | $14.11M | - | - | - |
| Financing Cash Flow | - | - | $1.75M | - | - | - | ($14.24M) | - | - | - |
| CapEx | - | - | $90.0K | - | - | - | $926.0K | - | - | - |
| Free Cash Flow | - | - | ($2.37M) | - | - | - | ($4.02M) | - | - | - |
Ratios
| Metric | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 46.4% | 52.3% | 47.9% | - | -0.6% | 47.1% | 31.0% | - | 9.8% | 37.3% |
| Operating margin | -58.9% | -19.7% | -33.5% | - | -1141.1% | -382.0% | -58.6% | - | -47.9% | -61.6% |
| EBITDA margin | -56.6% | -17.2% | -24.6% | - | -1132.5% | -376.5% | -56.0% | - | -43.3% | -46.7% |
| Net margin | -39.0% | -16.4% | 4.7% | - | -1114.2% | -362.9% | -42.8% | - | 23.3% | -65.6% |
| Free cash flow margin | - | - | -27.1% | - | - | - | -19.4% | - | - | - |
| FCF / Net income | - | - | -5.77 | - | - | - | 0.45 | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 87.4% | 91.7% | 81.4% | - | 123.0% | 108.6% | 90.6% | - | 57.7% | 98.8% |
| Effective tax rate | - | - | 61.6% | - | - | - | - | - | - | - |
| Return on assets | -9.2% | -3.8% | 1.0% | - | -222.7% | -35.3% | -3.6% | - | 2.1% | -3.8% |
| Return on equity | 9.1% | 4.3% | -1.2% | - | 284.7% | -82.5% | -6.3% | - | 2.8% | -6.9% |
| Return on invested capital | - | - | - | - | - | -62.4% | -6.5% | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.12 | 0.11 | 0.14 | 0.08 | 0.10 | 0.24 | 0.31 | 0.29 | 1.04 | 1.26 |
| Quick ratio | 0.08 | 0.05 | 0.08 | 0.04 | 0.06 | 0.16 | 0.21 | 0.21 | 0.66 | 1.19 |
| Cash ratio | 0.03 | 0.01 | 0.04 | 0.02 | 0.03 | 0.10 | 0.05 | 0.08 | 0.36 | 1.10 |
| Leverage | ||||||||||
| Debt / Equity | -0.11 | -0.20 | -0.65 | -0.13 | -0.19 | 0.10 | 0.05 | 0.07 | 0.07 | 0.06 |
| Debt / Assets | 0.11 | 0.17 | 0.55 | 0.12 | 0.15 | 0.04 | 0.03 | 0.04 | 0.05 | 0.03 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -5.4x | -9.3x | -2.9x | - | -319.8x | -151.4x | -6.9x | - | -15.2x | -18.9x |
| Equity multiplier | -0.99 | -1.14 | -1.17 | -1.11 | -1.28 | 2.33 | 1.78 | 1.91 | 1.32 | 1.79 |
| Liabilities / Assets | 2.01 | 1.88 | 1.85 | 1.90 | 1.78 | 0.57 | 0.42 | 0.46 | 0.24 | 0.44 |
| Efficiency | ||||||||||
| Asset turnover | 0.24 | 0.23 | 0.22 | - | 0.20 | 0.10 | 0.08 | - | 0.09 | 0.06 |
| Inventory turnover | 1.80 | 1.42 | 1.78 | - | 4.03 | 1.54 | 1.85 | - | 1.33 | 1.52 |
| Days sales outstanding | 54d | 36d | 28d | - | 19d | 18d | 71d | - | 131d | 128d |
| Days inventory outstanding | 202d | 257d | 205d | - | 90d | 237d | 197d | - | 274d | 241d |
| Days payable outstanding | 961d | 907d | 1043d | - | - | - | - | - | - | - |
| Cash conversion cycle | -705d | -614d | -810d | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -20.0% | -49.9% | -57.9% | - | -54.1% | 180.4% | 305.4% | - | 667.6% | 89.3% |
| Revenue CAGR (3y) | 41.3% | 38.5% | 26.5% | - | 12.3% | 19.2% | 41.2% | - | 49.0% | -10.4% |
| Revenue CAGR (5y) | 4.0% | 0.2% | 0.3% | - | 1.2% | 17.5% | 24.9% | - | 27.5% | -8.4% |
| Gross profit growth (YoY) | - | -44.4% | -35.0% | - | - | 253.7% | 164.5% | - | 59.1% | 68.0% |
| Operating income growth (YoY) | 95.9% | 97.4% | 75.9% | - | -993.8% | -1639.3% | -3.7% | - | 19.5% | 77.7% |
| Net income growth (YoY) | 97.2% | 97.7% | - | - | - | -1452.2% | 26.5% | - | - | 77.4% |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | 41.2% | - | - | - | -35.9% | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 12.7% | - | - | - | - | 29.8% | 120.4% | 141.2% | 457.1% | 13.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Business segments
$47.67M totalCannabis Retail$24.54M · 51.5%
Cannabis Cultivation Distributions$23.13M · 48.5%
Corporate And Other$2.0K · 0.0%
Geographic
$47.67M totalCA$42.12M · 88.4%
OR$5.55M · 11.6%
Peer comparison
Same SIC group: Retail-Miscellaneous Retail
Comparing Unrivaled Brands against the 5 most active filers in the same SIC group.